PSMA expression is mainly confined to the neovasculature of tumors and incidental findings of PSMA uptake were observed in hemangiomas in prostate cancer patients, suggesting overexpression of PSMA in vascular tumors [19–21]. This evidence concerns the gene FOLH1 and Familial prostate cancer.